CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $11,000 | +266.7% | 1,700 | +325.0% | 0.00% | – |
| Q2 2020 | $3,000 | -57.1% | 400 | -34.5% | 0.00% | – |
| Q2 2019 | $7,000 | +600.0% | 611 | +748.6% | 0.00% | – |
| Q3 2018 | $1,000 | -99.6% | 72 | -99.3% | 0.00% | -100.0% |
| Q2 2018 | $239,000 | +602.9% | 10,457 | +769.2% | 0.02% | +650.0% |
| Q1 2018 | $34,000 | +325.0% | 1,203 | +200.0% | 0.00% | +100.0% |
| Q4 2017 | $8,000 | +60.0% | 401 | +33.7% | 0.00% | – |
| Q2 2017 | $5,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,230,898 | $40,535,000 | 5.15% |
| Opaleye Management Inc. | 450,000 | $8,176,000 | 2.89% |
| EcoR1 Capital, LLC | 829,771 | $15,077,000 | 2.01% |
| Perceptive Advisors | 2,780,762 | $50,526,000 | 0.96% |
| Casdin Capital, LLC | 177,500 | $3,225,000 | 0.91% |
| Iguana Healthcare Management, LLC | 140,000 | $2,544,000 | 0.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 756,822 | $13,751,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 210,000 | $3,816,000 | 0.54% |
| HAMILTON LANE ADVISORS LLC | 28,346 | $515,000 | 0.35% |
| Tekla Capital Management LLC | 530,092 | $9,632,000 | 0.34% |